This site is intended for UK healthcare professionals only

Diabetes Professional Care
15-16 October 2024, Olympia London

The UK's leading event for the entire team involved in the prevention, treatment and management of diabetes and its related conditions.

Are you a UK healthcare professional?

We are unfortunately unable to allow patients to attend Diabetes Professional Care

If you would like more information on general practice or primary care, please refer to the NHS website.

Visit the NHS website

Legal Notice

DIABETES PROFESSIONAL CARE IS SUPPORTED BY THE PHARMACEUTICAL AND MED TECH INDUSTRIES VIA GRANTS, SPONSORSHIP, AND EXHIBITION PACKAGES. SESSIONS DELIVERED WITH INPUT FROM OUR SUPPORTERS WILL ALWAYS BE MARKED ON THE PROGRAMME.
A FULL LIST OF CONFIRMED SUPPORTERS FOR DIABETES PROFESSIONAL CARE CAN BE FOUND HERE.
 

News

Subpage Hero

     

03 Aug 2022

Researchers explore links between vitamin D deficiency and albuminuria in people living with type 2 diabetes

Researchers explore links between vitamin D deficiency and albuminuria in people living with type 2 diabetes

The relationship between vitamin D deficiency and the prevalence of albuminuria in the setting of type 2 diabetes has been investigated by researchers.

Around a third of people living with diabetes experience diabetic nephropathy, which is characterised by increased urinary albumin excretion and can lead to renal failure.

This prompted researchers from the Shiraz University of Medical Sciences in Iran to carry out a study involving 200 participants with type 2 diabetes between December 2019 and January 2021.

Their 25-hydroxyvitamin D (25OHD) serum level and urinary albumin-to-creatinine ratio (UACR) were measured before the participants were divided into three groups based on their albuminuria level.

Their 25OHD serum level and other clinical characteristics were then compared among these albuminuria groups, and the relation between albuminuria level and 25OHD was examined.

The team reported: “The prevalence of vitamin D deficiency in macroalbuminuric patients (UACR≥300 mg/g) was 61.8%, and in microalbuminuric (30 ≤ UACR< 300 mg/g) and normoalbuminuric groups (UACR< 30 mg/g) was 33.3% and 24%, respectively.

“Further analysis revealed a significant negative relationship between 25OHD and albuminuria (r = − 0.257, p-value< 0.001).

“According to ROC curve analysis, a 25OHD level ≤ 21 ng/ml was considered an optimal cut-off point value for having macroalbuminuria in diabetic patients.”

The study concluded that “the prevalence of macroalbuminuria increased when the 25OHD serum level was less than 20 ng/ml.”

The findings have been published in BMC Endocrine Disorders.

View all News
Loading

Partners

Education Partner

Education Partner

Event Partner

Event Partner

Event Partner

Event Partner

Event Partner

Event Partner

Event Partner

Event Partner

Event Partner

Media Partner